Fidelity Investments’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $700K | Sell |
205,741
-511,419
| -71% | -$1.74M | ﹤0.01% | 2844 |
|
|
2025
Q1 | $2.88M | Buy |
717,160
+33,973
| +5% | +$136K | ﹤0.01% | 2334 |
|
|
2024
Q4 | $4.43M | Buy |
683,187
+16,111
| +2% | +$105K | ﹤0.01% | 2200 |
|
|
2024
Q3 | $3.7M | Buy |
667,076
+30,386
| +5% | +$168K | ﹤0.01% | 2216 |
|
|
2024
Q2 | $3.55M | Buy |
636,690
+114,302
| +22% | +$638K | ﹤0.01% | 2184 |
|
|
2024
Q1 | $3.51M | Sell |
522,388
-23
| -0% | -$154 | ﹤0.01% | 2175 |
|
|
2023
Q4 | $4.76M | Buy |
522,411
+2,668
| +0.5% | +$24.3K | ﹤0.01% | 2082 |
|
|
2023
Q3 | $2.87M | Buy |
519,743
+375
| +0.1% | +$2.07K | ﹤0.01% | 2184 |
|
|
2023
Q2 | $4.44M | Buy |
519,368
+1,208
| +0.2% | +$10.3K | ﹤0.01% | 2100 |
|
|
2023
Q1 | $4.76M | Sell |
518,160
-17,501
| -3% | -$161K | ﹤0.01% | 2108 |
|
|
2022
Q4 | $5.47M | Sell |
535,661
-59,412
| -10% | -$607K | ﹤0.01% | 2090 |
|
|
2022
Q3 | $8.76M | Buy |
595,073
+74,228
| +14% | +$1.09M | ﹤0.01% | 1959 |
|
|
2022
Q2 | $5.59M | Buy |
520,845
+2,616
| +0.5% | +$28.1K | ﹤0.01% | 2202 |
|
|
2022
Q1 | $5.59M | Sell |
518,229
-2,148,371
| -81% | -$23.2M | ﹤0.01% | 2336 |
|
|
2021
Q4 | $43.5M | Hold |
2,666,600
| – | – | ﹤0.01% | 1483 |
|
|
2021
Q3 | $57.1M | Buy |
+2,666,600
| New | +$57.1M | ﹤0.01% | 1358 |
|